Bushnell, J., Hammers, D. B., Aisen, P., Dage, J. L., Eloyan, A., Foroud, T., Grinberg, L. T., Iaccarino, L., Jack, C. R., Kirby, K., Kramer, J., Koeppe, R., Kukull, W. A., La Joie, R., Mundada, N. S., Murray, M. E., Nudelman, K., Rumbaugh, M., … Soleimani‐Meigooni, D. N. (2023). Influence of amyloid and diagnostic syndrome on non‐traditional memory scores in early‐onset Alzheimer’s disease. Alzheimer’s & Dementia, 19(S9). Portico. https://doi.org/10.1002/alz.13434

Polsinelli, A. J., Wonderlin, R. J., Hammers, D. B., Garcia, A. P., Eloyan, A., Taurone, A., Thangarajah, M., Beckett, L., Gao, S., Wang, S., Kirby, K., Logan, P. E., Aisen, P., Dage, J. L., Foroud, T., Griffin, P., Iaccarino, L., Kramer, J. H., … Koeppe, R. (2023). Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early‐Onset Alzheimer’s Disease Study (LEADS) cohort. Alzheimer’s & Dementia, 19(S9). Portico. https://doi.org/10.1002/alz.13344

Nemes, S., Logan, P. E., Manchella, M. K., Mundada, N. S., La Joie, R., Polsinelli, A. J., Hammers, D. B., Koeppe, R. A., Foroud, T. M., Nudelman, K. N., Eloyan, A., Iaccarino, L., Dorsant‐Ardón, V., Taurone, A., Thangarajah, M., Dage, J. L., Aisen, P., Grinberg, L. T., … Jack, C. R. (2023). Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early‐onset Alzheimer’s disease. Alzheimer’s & Dementia, 19(S9). Portico. https://doi.org/10.1002/alz.13403

Touroutoglou, A., Katsumi, Y., Brickhouse, M., Zaitsev, A., Eckbo, R., Aisen, P., Beckett, L., Dage, J. L., Eloyan, A., Foroud, T., Ghetti, B., Griffin, P., Hammers, D., Jack, C. R., Kramer, J. H., Iaccarino, L., Joie, R. L., Mundada, N. S., … Koeppe, R. (2023). The Sporadic Early‐onset Alzheimer’s Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early‐onset Alzheimer’s Disease Study (LEADS) Cohort. Alzheimer’s & Dementia, 19(S9). Portico. https://doi.org/10.1002/alz.13466

Fernández, K. K., Kociolek, A. J., Lao, P. J., Stern, Y., Manly, J. J., & Vonk, J. M. J. (2023). Longitudinal decline in semantic versus letter fluency, but not their ratio, marks incident Alzheimer’s disease in Latinx Spanish-speaking older individuals. Journal of the International Neuropsychological Society, 29(8), 775–782. https://doi.org/10.1017/s1355617722000856

Parato, J., Peris, L., Qu, X., Goldberg, Y., Moutin, M.-J., Andrieux, A., & Bartolini, F. (2023). IMPAIRED α-TUBULIN RE-TYROSINATION LEADS TO SYNAPTIC DYSFUNCTION AND IS A FEATURE OF ALZHEIMER’S DISEASE. IBRO Neuroscience Reports, 15, S34. https://doi.org/10.1016/j.ibneur.2023.08.2116

Jain, L., Khrestian, M., Formica, S., Tuason, E. D., Pillai, J. A., Rao, S., Oguh, O., Lippa, C. F., Lopez, O. L., Berman, S. B., Tsuang, D. W., Zabetian, C. P., Irwin, D. J., Galasko, D. R., Litvan, I., Marder, K. S., Honig, L. S., Fleisher, J. E., Galvin, J. E., … Bekris, L. M. (2023). ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium. Alzheimer’s & Dementia, 20(1), 549–562. Portico. https://doi.org/10.1002/alz.13398

Wagemann, O., Li, Y., Hassenstab, J., Aschenbrenner, A. J., McKay, N. S., Gordon, B. A., Benzinger, T. L. S., Xiong, C., Cruchaga, C., Renton, A. E., Perrin, R. J., Berman, S. B., Chhatwal, J. P., Farlow, M. R., Day, G. S., Ikeuchi, T., Jucker, M., Lopera, F., … Mori, H. (2023). Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network. Alzheimer’s & Dementia, 20(1), 47–62. Portico. https://doi.org/10.1002/alz.13460

Cho, H., Mundada, N. S., Apostolova, L. G., Carrillo, M. C., Shankar, R., Amuiri, A. N., Zeltzer, E., Windon, C. C., Soleimani‐Meigooni, D. N., Tanner, J. A., Heath, C. L., Lesman‐Segev, O. H., Aisen, P., Eloyan, A., Lee, H. S., Hammers, D. B., Kirby, K., Dage, J. L., … Fagan, A. (2023). Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer’s Disease Study (LEADS). Alzheimer’s & Dementia, 19(S9). Portico. https://doi.org/10.1002/alz.13453

Qi, R., Sammler, E., Gonzalez-Hunt, C. P., Barraza, I., Pena, N., Rouanet, J. P., Naaldijk, Y., Goodson, S., Fuzzati, M., Blandini, F., Erickson, K. I., Weinstein, A. M., Lutz, M. W., Kwok, J. B., Halliday, G. M., Dzamko, N., Padmanabhan, S., Alcalay, R. N., Waters, C., … Sanders, L. H. (2023). A blood-based marker of mitochondrial DNA damage in Parkinson’s disease. Science Translational Medicine, 15(711). https://doi.org/10.1126/scitranslmed.abo1557

McKay, N. S., Gordon, B. A., Hornbeck, R. C., Dincer, A., Flores, S., Keefe, S. J., Joseph-Mathurin, N., Jack, C. R., Koeppe, R., Millar, P. R., Ances, B. M., Chen, C. D., Daniels, A., Hobbs, D. A., Jackson, K., Koudelis, D., Massoumzadeh, P., McCullough, A., Nickels, M. L., … la Fougère, C. (2023). Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nature Neuroscience, 26(8), 1449–1460. https://doi.org/10.1038/s41593-023-01359-8

Agrawal, R. R., Larrea, D., Xu, Y., Shi, L., Zirpoli, H., Cummins, L. G., Emmanuele, V., Song, D., Yun, T. D., Macaluso, F. P., Min, W., Kernie, S. G., Deckelbaum, R. J., & Area-Gomez, E. (2022). Alzheimer’s-Associated Upregulation of Mitochondria-Associated ER Membranes After Traumatic Brain Injury. Cellular and Molecular Neurobiology, 43(5), 2219–2241. https://doi.org/10.1007/s10571-022-01299-0

Ali, M., Mafimoghaddam, S., Sung, Y. J., Wang, F., Fernandez, M. V., Archer, D. B., Hohman, T. J., Satizabal, C. L., Yang, Q., Beiser, A. S., Wang, R., Gordon, B. A., Benzinger, T. L. S., Xiong, C., Morris, J. C., Bateman, R. J., Karch, C. M., McDade, E., Goate, A., … Cruchaga, C. (2023). Using amyloid PET as a biomarker to detect progression of early Alzheimer disease. Alzheimer’s & Dementia, 19(S3). Portico. https://doi.org/10.1002/alz.066189

Hayden, K. M., Evans, J. K., Culkin, M. C., Molina‐Henry, D. P., Marcovina, S., Shappell, H. M., Rapp, S. R., Sachs, B. C., Ding, J., Mielke, M. M., Luchsinger, J. A., & Espeland, M. A. (2023). The association between Alzheimer’s disease blood‐based biomarkers and cognitive impairment and probable dementia in Look AHEAD MIND. Alzheimer’s & Dementia, 19(S2). Portico. https://doi.org/10.1002/alz.063408

Vöglein, J., Franzmeier, N., Morris, J. C., Dieterich, M., McDade, E., Simons, M., Preische, O., Hofmann, A., Hassenstab, J., Benzinger, T. L., Fagan, A., Noble, J. M., Berman, S. B., Graff‐Radford, N. R., Ghetti, B., Farlow, M. R., Chhatwal, J. P., Salloway, S., … Xiong, C. (2022). Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease. Alzheimer’s & Dementia, 19(2), 632–645. Portico. https://doi.org/10.1002/alz.12684

Shuping, J. L., Matthews, D. C., Adamczuk, K., Scott, D., Rowe, C. C., Kreisl, W. C., Johnson, S. C., Lukic, A. S., Johnson, K. A., Rosa‐Neto, P., Andrews, R. D., Van Laere, K., Cordes, L., Ward, L., Wilde, C. L., Barakos, J., Purcell, D. D., Devanand, D. P., Stern, Y., … Evelhoch, J. L. (2023). Development, initial validation, and application of a visual read method for [18F]MK‐6240 tau PET. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 9(1). Portico. https://doi.org/10.1002/trc2.12372

Hani Hojjati, S., Butler, T. A., Chiang, G. C., Habeck, C., RoyChoudhury, A., Feiz, F., Shteingart, J., Nayak, S., Ozoria, S., Fernández, A., Stern, Y., Luchsinger, J. A., Devanand, D. P., & Razlighi, Q. R. (2023). Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness. NeuroImage: Clinical, 38, 103409. https://doi.org/10.1016/j.nicl.2023.103409

Lee, A., Kondapalli, C., Virga, D. M., Lewis, T. L., Koo, S. Y., Ashok, A., Mairet-Coello, G., Herzig, S., Foretz, M., Viollet, B., Shaw, R., Sproul, A., & Polleux, F. (2022). Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-32130-5

Duong, M. T., Das, S. R., Lyu, X., Xie, L., Richardson, H., Xie, S. X., Yushkevich, P. A., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., Toga, A. W., Beckett, L., Green, R. C., Saykin, A. J., Morris, J. C., … Nasrallah, I. M. (2022). Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-28941-1

McLachlan, M., Price, J. C., Laymon, C. M., Garimella, A., Keator, D. B., Kreisl, W. C., Klunk, W. E., Fryer, T. D., McVea, A. K., DiFilippo, A. H., & Christian, B. T. (2022). Early striatal amyloid signal in Down Syndrome: Comparison of PiB and Florbetapir PET. Alzheimer’s & Dementia, 18(S5). Portico. https://doi.org/10.1002/alz.062459

Pichet Binette, A., Franzmeier, N., Spotorno, N., Ewers, M., Brendel, M., Biel, D., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., Toga, A. W., Beckett, L., Green, R. C., Saykin, A. J., Morris, J., Shaw, L. M., … Hansson, O. (2022). Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-34129-4

Joseph‐Mathurin, N., Llibre‐Guerra, J. J., Li, Y., McCullough, A. A., Hofmann, C., Wojtowicz, J., Park, E., Wang, G., Preboske, G. M., Wang, Q., Gordon, B. A., Chen, C. D., Flores, S., Aggarwal, N. T., Berman, S. B., Bird, T. D., Black, S. E., Borowski, B., … Brooks, W. S. (2022). Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. Annals of Neurology, 92(5), 729–744. Portico. https://doi.org/10.1002/ana.26511

Ostrowitzki, S., Bittner, T., Sink, K. M., Mackey, H., Rabe, C., Honig, L. S., Cassetta, E., Woodward, M., Boada, M., van Dyck, C. H., Grimmer, T., Selkoe, D. J., Schneider, A., Blondeau, K., Hu, N., Quartino, A., Clayton, D., Dolton, M., Dang, Y., … Doody, R. S. (2022). Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease. JAMA Neurology, 79(11), 1113. https://doi.org/10.1001/jamaneurol.2022.2909

Seto, M., Weiner, R. L., Dumitrescu, L., Mahoney, E. R., Hansen, S. L., Janve, V., Khan, O. A., Liu, D., Wang, Y., Menon, V., De Jager, P. L., Schneider, J. A., Bennett, D. A., Gifford, K. A., Jefferson, A. L., & Hohman, T. J. (2022). RNASE6 is a novel modifier of APOE-ε4 effects on cognition. Neurobiology of Aging, 118, 66–76. https://doi.org/10.1016/j.neurobiolaging.2022.06.011

Mishra, R., Phan, T., Kumar, P., Morrissey, Z., Gupta, M., Hollands, C., Shetti, A., Lopez, K. L., Maienschein-Cline, M., Suh, H., Hen, R., & Lazarov, O. (2022). Augmenting neurogenesis rescues memory impairments in Alzheimer’s disease by restoring the memory-storing neurons. Journal of Experimental Medicine, 219(9). https://doi.org/10.1084/jem.20220391

Manzali, S. B., Yu, E., Ravona-Springer, R., Livny, A., Golan, S., Ouyang, Y., Lesman-Segev, O., Liu, L., Ganmore, I., Alkelai, A., Gan-Or, Z., Lin, H.-M., Heymann, A., Schnaider Beeri, M., & Greenbaum, L. (2022). Alzheimer’s Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes. Frontiers in Aging Neuroscience, 14. https://doi.org/10.3389/fnagi.2022.853695

Martínez-Hernández, J., Parato, J., Sharma, A., Soleilhac, J.-M., Qu, X., Tein, E., Sproul, A., Andrieux, A., Goldberg, Y., Moutin, M.-J., Bartolini, F., & Peris, L. (2022). Crosstalk between acetylation and the tyrosination/detyrosination cycle of α-tubulin in Alzheimer’s disease. Frontiers in Cell and Developmental Biology, 10. https://doi.org/10.3389/fcell.2022.926914

Rabin, J. S., Nichols, E., La Joie, R., Casaletto, K. B., Palta, P., Dams-O’Connor, K., Kumar, R. G., George, K. M., Satizabal, C. L., Schneider, J. A., Pa, J., & Brickman, A. M. (2022). Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain, 145(8), 2823–2833. https://doi.org/10.1093/brain/awac178

Damuka, N., Orr, M. E., Bansode, A. H., Krizan, I., Miller, M., Lee, J., Macauley, S. L., Whitlow, C. T., Mintz, A., Craft, S., & Solingapuram Sai, K. K. (2022). Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model. EJNMMI Research, 12(1). https://doi.org/10.1186/s13550-022-00912-z

Peris, L., Parato, J., Qu, X., Soleilhac, J. M., Lanté, F., Kumar, A., Pero, M. E., Martínez-Hernández, J., Corrao, C., Falivelli, G., Payet, F., Gory-Fauré, S., Bosc, C., Blanca Ramirez, M., Sproul, A., Brocard, J., Di Cara, B., Delagrange, P., Buisson, A., … Andrieux, A. (2022). Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease. Brain, 145(7), 2486–2506. https://doi.org/10.1093/brain/awab436

Eissman, J. M., Dumitrescu, L., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., Scollard, P., Choi, S. E., Bush, W. S., Engelman, C. D., Lu, Q., Fardo, D. W., Trittschuh, E. H., Mez, J., Kaczorowski, C. C., Hernandez Saucedo, H., Widaman, K. F., Buckley, R. F., Properzi, M. J., … Hohman, T. J. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Brain, 145(7), 2541–2554. https://doi.org/10.1093/brain/awac177

Consens, M. E., Chen, Y., Menon, V., Wang, Y., Schneider, J. A., De Jager, P. L., Bennett, D. A., Tripathy, S. J., & Felsky, D. (2022). Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer’s Disease. Frontiers in Molecular Neuroscience, 15. https://doi.org/10.3389/fnmol.2022.903175

Wang, Q., de Prisco, N., Tang, J., & Gennarino, V. A. (2022). Protocol for recording epileptiform discharges of EEG and behavioral seizures in freely moving mice. STAR Protocols, 3(2), 101245. https://doi.org/10.1016/j.xpro.2022.101245

Connor, S. M., Rashid, M., Ryan, K. J., Patel, K., Boyd, J. D., Smith, J., Elyaman, W., Bennett, D. A., & Bradshaw, E. M. (2022). GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer’s Disease. Frontiers in Cellular Neuroscience, 16. https://doi.org/10.3389/fncel.2022.894601

Chang, A., Xiang, X., Wang, J., Lee, C., Arakhamia, T., Simjanoska, M., Wang, C., Carlomagno, Y., Zhang, G., Dhingra, S., Thierry, M., Perneel, J., Heeman, B., Forgrave, L. M., DeTure, M., DeMarco, M. L., Cook, C. N., Rademakers, R., Dickson, D. W., … Fitzpatrick, A. W. P. (2022). Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell, 185(8), 1346-1355.e15. https://doi.org/10.1016/j.cell.2022.02.026

Barker, M. S., Gottesman, R. T., Manoochehri, M., Chapman, S., Appleby, B. S., Brushaber, D., Devick, K. L., Dickerson, B. C., Domoto-Reilly, K., Fields, J. A., Forsberg, L. K., Galasko, D. R., Ghoshal, N., Goldman, J., Graff-Radford, N. R., Grossman, M., Heuer, H. W., Hsiung, G.-Y., Knopman, D. S., … Weintraub, S. (2022). Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain, 145(3), 1079–1097. https://doi.org/10.1093/brain/awab365

Singh, H. N., Swarup, V., Dubey, N. K., Jha, N. K., Singh, A. K., Lo, W.-C., & Kumar, S. (2022). Differential Transcriptome Profiling Unveils Novel Deregulated Gene Signatures Involved in Pathogenesis of Alzheimer’s Disease. Biomedicines, 10(3), 611. https://doi.org/10.3390/biomedicines10030611

Zammit, A. R., Yu, L., Petyuk, V., Schneider, J. A., De Jager, P. L., Klein, H.-U., Bennett, D. A., & Buchman, A. S. (2022). Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults. Neurology, 98(13). https://doi.org/10.1212/wnl.0000000000200017

Zhuravleva, V., Vaz-Silva, J., Zhu, M., Gomes, P., Silva, J. M., Sousa, N., Sotiropoulos, I., & Waites, C. L. (2021). Rab35 and glucocorticoids regulate APP and BACE1 trafficking to modulate Aβ production. Cell Death & Disease, 12(12). https://doi.org/10.1038/s41419-021-04433-w

Klein, H.-U., Trumpff, C., Yang, H.-S., Lee, A. J., Picard, M., Bennett, D. A., & De Jager, P. L. (2021). Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain. Molecular Neurodegeneration, 16(1). https://doi.org/10.1186/s13024-021-00495-8

Lao, P. J., Berroa, J., Benavides, A., Tejeda, E., Shouel, H., Igwe, K., Maas, B., Schupf, N., Mayeux, R., Manly, J. J., & Brickman, A. M. (2021). Amyloid and tau PET in a middle‐aged, racially and ethnically diverse, community‐based cohort. Alzheimer’s & Dementia, 17(S4). Portico. https://doi.org/10.1002/alz.050953

Dubois, B., Villain, N., Frisoni, G., Rabinovici, G. D., Sabbagh, M. N., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., Habert, M., Nordberg, A. K., Blennow, K., Galasko, D. R., Stern, Y., Rowe, C. C., Salloway, S. P., Schneider, L. S., Cummings, J. L., & Feldman, H. (2021). Recommendations of the International Working Group for the clinical diagnosis of Alzheimer’s disease. Alzheimer’s & Dementia, 17(S5). Portico. https://doi.org/10.1002/alz.057538

Beebe-Wang, N., Celik, S., Weinberger, E., Sturmfels, P., De Jager, P. L., Mostafavi, S., & Lee, S.-I. (2021). Unified AI framework to uncover deep interrelationships between gene expression and Alzheimer’s disease neuropathologies. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-25680-7

Llibre‐Guerra, J. J., Li, Y., Franklin, E. E., Miller, C. A., Teich, A. F., Kofler, J., Dickson, D. W., Ghetti, B. F., Frosch, M. P., Halliday, G. M., McLean, C., Lashley, T., Gordon, B. A., Schindler, S. E., Chen, C. D., Fagan, A. M., Benzinger, T. L. S., Wang, G., Hassenstab, J., … McDade, E. (2021). Presence of co‐pathology in sporadic early‐onset Alzheimer disease versus dominantly inherited Alzheimer disease. Alzheimer’s & Dementia, 17(S3). Portico. https://doi.org/10.1002/alz.055045

Hunsberger, H. C., Setti, S. E., Rudy, C. C., Weitzner, D. S., Pfitzer, J. C., McDonald, K. L., Hong, H., Bhattacharya, S., Suppiramaniam, V., & Reed, M. N. (2021). Differential Effects of Human P301L Tau Expression in Young versus Aged Mice. International Journal of Molecular Sciences, 22(21), 11637. https://doi.org/10.3390/ijms222111637

Kim, S. H., Farrell, K., Cosentino, S., Vonsattel, J.-P. G., Faust, P. L., Cortes, E. P., Bennet, D. A., Louis, E. D., & Crary, J. F. (2021). Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies. Journal of Neuropathology & Experimental Neurology, 80(9), 835–843. https://doi.org/10.1093/jnen/nlab073